The Current Ratio as of September 2024 (TTM) for Avenue Therapeutics, Inc. (ATXI) is 4.30

According to Avenue Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.30. This represents a change of 107.37% compared to the average of 2.07 of the last 4 quarters.

Avenue Therapeutics, Inc. (ATXI) Historical Current Ratio (quarterly & annually)

How has ATXI Current Ratio performed in the past?

The mean historical Current Ratio of Avenue Therapeutics, Inc. over the last ten years is 3.11. The current 4.30 Current Ratio has changed 13.72% with respect to the historical average. Over the past ten years (40 quarters), ATXI's Current Ratio was at its highest in in the September 2017 quarter at 13.15. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Avenue Therapeutics, Inc. (ATXI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Avenue Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Avenue Therapeutics, Inc. (ATXI) Average Current Ratio

How has ATXI Current Ratio performed in the past?

The current Current Ratio of Avenue Therapeutics, Inc. (ATXI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Avenue Therapeutics, Inc. (ATXI) Current Ratio vs. Peers

How is ATXI’s Current Ratio compared to its peers?

Avenue Therapeutics, Inc.’s Current Ratio is less than Hoth Therapeutics, Inc. (14.62), greater than Revelation Biosciences, Inc. (1.10), greater than NeuroBo Pharmaceuticals, Inc. (2.94), less than Virax Biolabs Group Limited (25.94), greater than Panbela Therapeutics, Inc. (0.05), less than Palisade Bio, Inc. (4.31), greater than Quoin Pharmaceuticals, Ltd. (3.35), greater than ContraFect Corporation (0.53), greater than Allarity Therapeutics, Inc. (2.01), greater than CNS Pharmaceuticals, Inc. (0.31), greater than Windtree Therapeutics, Inc. (0.23), less than Kiromic BioPharma, Inc. (0), greater than Biodexa Pharmaceuticals Plc (0.35), greater than null (1.26),

Build a custom stock screener for Avenue Therapeutics, Inc. (ATXI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avenue Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avenue Therapeutics, Inc. (ATXI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avenue Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.